Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA flags safety risks for Lilly antipsychotic drug
FDA flags safety risks for Lilly antipsychotic drug
FDA flags safety risks for Lilly antipsychotic drug
Submitted by
admin
on May 10, 2016 - 3:06pm
Source:
BioPharma Dive
News Tags:
FDA
Eli Lilly
antipsychotics
Symbyax
Zyprexa
Olanzapine
Headline:
FDA flags safety risks for Lilly antipsychotic drug
Do Not Allow Advertisers to Use My Personal information
